Company: OXLCZ
Filing Date: 2025-02-19
Form Type: 424B2
Source: 0001213900-25-015045
Chunk: 3

Company: Oxford Lane Capital Corp.
Filing Date: 2025-02-19
Form: 424B2
Chunk 3
---
 for the Notes and there can be no assurance that one will develop. Investing in the Notes involves a high degree of risk. Before investing in the Notes, you should read the discussion of the material risks of investing in the Notes beginning on page S -16 of this prospectus supplement, as well as the “Risk Factors” beginning on page 15 of the accompanying prospectus, including the risk of leverage, or otherwise incorporated by reference herein or therein and included in, or incorporated by reference into, any free writing prospectuses we have authorized for use in connection with a specific offering, and under similar headings in the other documents that are incorporated by reference into this prospectus supplement or the accompanying prospectus. Please read this prospectus supplement, the accompanying prospectus and the documents incorporated by reference into this prospectus supplement and the accompanying prospectus before investing in the Notes and keep each for future reference. This prospectus supplement, the accompanying prospectus and the documents incorporated by reference into this prospectus supplement and the accompanying prospectus contain important information about us that a prospective investor should know before investing in the Notes. We are required to file annual and semi -annualreports, proxy statements and other information about us with the Securities and Exchange Commission, or “SEC.” This information is available free of charge by contacting us by mail at 8 Sound Shore Drive, Suite 255, Greenwich, CT 06830, by telephone at (203) 983 -5275or on our website at http://www.oxfordlanecapital.com. The SEC also maintains a website at http://www.sec.govthat contains such information. Information contained on our website is not incorporated by reference into this prospectus supplement or the accompanying prospectus, and you should not consider that information to be part of this prospectus supplement or the accompanying prospectus, except documents incorporated by reference into this prospectus supplement or the accompanying prospectus. The underwriters have agreed to purchase the Notes from us at% of the aggregate principal amount of the Notes (resulting in $in aggregate proceeds to us, before deducting expenses payable by us).

|                                                     |     | Per Note |     | Total(1)(2) |
|:----------------------------------------------------|:----|:---------|:----|:------------|
| Public Offering Price                               |     | $        |     | $           |
| Sales Load (underwriting discounts and commissions) |     | $        |     | $           |
| Proceeds to the Company (before expenses)(2)        |     |